Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
โ Scribed by David Yiu-Kuen But; Ching-Lung Lai; Wei-Ling Lim; James Fung; Danny Ka-Ho Wong; Man-Fung Yuen
- Book ID
- 116960952
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 246 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A total of 318 children were prospectively randomized in group 1 with two 5-g doses of recombinant vaccine given at 0 and 1 month; in group 2 with three 5-g doses of recombinant vaccine given at 0, 1, and 6 months; or in group 3 with three doses of plasma-derived vaccine given at 0, 1, and 6 months.
In a prospective randomized trial, 318 children aged between 3 mo and 11 yr who were negative for all hepatitis B markers were randomized to receive two 5-pg doses of hepatitis B recombinant DNA yeast vaccine at 0 and 1 m o (group 11, three 5 -~g doses of hepatitis B recombinant DNA yeast vaccine at